Corautus genetics
WebIn addition to Biogen Idec Inc. and GeneSys Therapeutics Corp, Dr. Sobol was a co-founder, senior executive, and board member of GenStar Therapeutics Corp and Corautus Genetics Inc. Dr. Sobol trained in internal medicine and oncology at the University of Southern California (USC) Medical Center, Mercy Hospital in San Diego and UCSD receiving ... WebMANUFACTURING AGREEMENT FOR CLINICAL TRIAL AND COMMERCIAL SUPPLY B E T W E E N: CORAUTUS GENETICS INC. a corporation incorporated under the laws of Delaware, having its corporate head office and principal place of business at Atlanta, GA 30308, USA... Document Metadata Filed: May 19th, 2005 Contract TypeManufacturing …
Corautus genetics
Did you know?
WebCorautus Genetics Overview Update this profile Founded 1995 Status Acquired/ Merged Latest Deal Type M&A Financing Rounds 4 Investments 1 General Information … WebJul 13, 2006 · Corautus expects to present the results from the trial in the fall of 2006. Richard E. Otto, President and Chief Executive Officer of Corautus, said, "A major clinical and regulatory focus for the past few months has been to successfully respond to the issues raised by the FDA in the clinical hold letter of March 29, 2006.
WebJun 29, 2005 · Corautus Genetics Inc. is adding $23 million through a few different transactions, two private stock sales and a loan. A group of private investors and Corautus' largest stockholder, Boston Scientific Corp., agreed to buy about 4.7 million common shares in two deals for proceeds of about $18 million. At the same time, Boston Scientific … WebJun 5, 2007 · VIA Pharmaceuticals, Inc. (NASDAQ: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today the completion of its merger transaction with Corautus Genetics Inc. and its receipt of an extension from the NASDAQ Listings Qualifications Panel until June 29, …
WebAbout Corautus Genetics Inc. Corautus is a development stage company dedicated to the development of innovative products in the life sciences industry. Corautus, … WebFeb 8, 2007 · Corautus Genetics Inc. CONTACT: Jack W. Callicutt, Senior Vice President and Chief FinancialOfficer of Corautus Genetics Inc., +1-404-526-6210; or James G. Stewart,Senior Vice President and Chief Financial Officer of VIA Pharmaceuticals,Inc., …
WebCorautus Genetics 10 followers on LinkedIn. ... Horizons Greater Washington Non-profit Organizations Washington, District of Columbia
WebCORAUTUS GENETICS INC. was registered on Feb 12 2003 as a foreign profit corporation type with the address 70 Mansell Court , Suite 100, Roswell, GA, 30076. The company id … lamina fibrosa kernWebCorautus Genetics's latest funding round is Acquired. How much did Corautus Genetics raise? Corautus Genetics raised a total of $41.45M. Who are the investors of Corautus Genetics? Investors of Corautus Genetics include VIA Pharmaceuticals, Iroquois Capital Group, Walters Group, Boston Scientific, Bluegrass Growth Fund Partners and 13 more. ... lamina engargolada kr-18WebHe also formerly served as outside general counsel to REACH Health, Inc., and to Corautus Genetics, Inc. and its predecessor Vascular Genetics, Inc. Bob has been an advisor to senior management and boards of directors and advises management and boards on their roles and responsibilities in both the private and public company context. jes9003WebCorautus Genetics Overview Update this profile Founded 1995 Status Acquired/ Merged Latest Deal Type M&A Financing Rounds 4 Investments 1 General Information Description Operator of a biotechnology company. The company is engaged in developing products for the treatment of hemophilia A and prostate cancer. Contact Information Formerly Known As lamina dura diagramWebCorautus Genetics Inc., is located at Atlanta, GA and dedicated to the clinical development of new therapies for the treatment of patients with serious diseases, including severe … jes830jes 8 srlWebIn addition to Biogen Idec Inc. and GeneSys Therapeutics Corp, Dr. Sobol was a co-founder, senior executive, and board member of GenStar Therapeutics Corp and Corautus Genetics Inc. Dr. Sobol... laminae perfume petala beauty